Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2006-10-31
2006-10-31
Wilson, James O. (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C536S017400, C536S007100
Reexamination Certificate
active
07129221
ABSTRACT:
The present invention discloses compounds of formula I, or pharmaceutically acceptable salts, esters, or prodrugs thereof:which exhibit antibacterial properties. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject in need of antibiotic treatment. The invention also relates to methods of treating a bacterial infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention. The invention further includes process by which to make the compounds of the present invention.
REFERENCES:
patent: 4990602 (1991-02-01), Morimoto et al.
patent: 5403923 (1995-04-01), Kashimura et al.
patent: 5444051 (1995-08-01), Agouridas et al.
patent: 5527780 (1996-06-01), Agouridas et al.
patent: 5631355 (1997-05-01), Asaka et al.
patent: 5866549 (1999-02-01), Or et al.
patent: 5969161 (1999-10-01), Bonnet et al.
patent: 6046171 (2000-04-01), Or et al.
patent: 6124269 (2000-09-01), Phan et al.
patent: 6399582 (2002-06-01), Hlasta et al.
patent: 6878691 (2005-04-01), Or et al.
patent: WO 99 21864 (1999-05-01), None
U.S. Appl. No. 10/429,485, filed May 5, 2003, Or et al.
International Search Report of International Application No. PCT/US 03/14914, Applicant: Enanta Pharmaceuticals, Inc.; Applicant's File Reference ENP-034 PCT, Jul. 30, 2003.
Farmer Jay Judson
Hou Ying
Niu Deqiang
Or Yat Sun
Phan Ly Tam
Elmore Carolyn S.
Elmore, Craig & Vanstone, P.C.
Enanta Pharmaceuticals, Inc.
Krishnan Ganapathy
Vanstone Darlene A.
LandOfFree
6,11-bicyclic erythromycin derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 6,11-bicyclic erythromycin derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 6,11-bicyclic erythromycin derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3648033